700834-18-0

Basic information

• Product Name: Benzoic acid, 4-(formylamino)-3-methoxy-, methyl ester (9CI)
• Synonyms: Benzoic acid, 4-(formylamino)-3-methoxy-, methyl ester (9CI);METHYL 4-FORMYLAMINO-3-METHOXYBENZOATE;Methyl 4-(formylamino)-3-methoxybenzenecarboxylate;Methyl 4-forMaMido-3-Methoxybenzoate;4-ForMylaMino-3-Methoxy-benzoic acid Methyl ester;Benzoic acid, 4-(formylamino)-3-methoxy-, methyl ester
• CAS NO: 700834-18-0
• Molecular Formula: C₁₀H₁₁NO₄
• Molecular Weight: 209.19864
• Product Categories: AMINOACID
• Mol File: 700834-18-0.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Benzoic acid, 4-(formylamino)-3-methoxy-, methyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-(formylamino)-3-methoxy-, methyl ester (9CI)(700834-18-0)
• EPA Substance Registry System: Benzoic acid, 4-(formylamino)-3-methoxy-, methyl ester (9CI)(700834-18-0)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 700834-18-0(Hazardous Substances Data)

Usage

General Description

Benzoic acid, 4-(formylamino)-3-methoxy-, methyl ester (9CI) is a chemical compound with the molecular formula C10H11NO4. It is a methyl ester derivative of 4-(formylamino)-3-methoxybenzoic acid, and is also known by its systematic name methyl 4-(formylamino)-3-methoxybenzoate. Benzoic acid, 4-(formylamino)-3-methoxy-, methyl ester (9CI) is used in various industrial and pharmaceutical applications, and is known for its potential anti-inflammatory and analgesic properties. However, it is also important to note that this chemical compound may have potential hazards and precautions should be taken when handling it, as it can cause irritation to the skin, eyes, and respiratory system.

Upstream product

• 64-18-6 formic acid 
• 41608-64-4 methyl 3-methoxy-4-aminobenzoate 
• 5081-37-8 methyl 3-methoxy-4-nitrobenzoate 
• 619-14-7 3-hydroxy-4-nitro-benzoic acid 
• 2258-42-6 formyl acetic anhydride 

Downstream Products

• 870837-20-0 4-[formyl-(2-oxopropyl)amino]-3-methoxybenzoic acid methyl ester 
• 870837-18-6 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde 
• 870839-41-1 (E)-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]acrylic acid 
• 870837-70-0 4-(1H-imidazol-1-yl)-3-methoxybenzaldehyde 
• 870837-69-7 4-(5-chloro-1H-imidazol-1-yl)-3-methoxybenzaldehyde 
• 870837-68-6 4-(2-chloro-1H-imidazol-1-yl)-3-methoxybenzaldehyde 
• 870838-69-0 (E)-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]acrylic acid ethyl ester 
• 1363146-44-4 ethyl 8-chloro-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine-8-carboxylate 
• 1363146-39-7 ethyl 3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine-8-carboxylate 
• 1363145-33-8 ethyl 8-(3,4-difluorophenyl)-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine-8-carboxylate 
• 1262106-88-6 tert-butyl 2-{[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]carbonyl}hydrazinecarboxylate 
• 1242314-39-1 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzohydrazide 
• 937026-26-1 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzoic acid 
• 870837-21-1 3-methoxy-4-(4-methylimidazol-1-yl)benzoic acid methyl ester 

Relevant articles and documents

HETEROCYCLIC COMPOUND AND USE THEREOF

The present invention provides a heterocycle derivative having a superior amyloid β production inhibitory activity and/or a superior γ-secretase modulation activity, and use thereof. A compound represented by the formula (I): wherein each symbol is as defined in the present specification, or a salt thereof.

PROCESS FOR PRODUCTION OF CINNAMAMIDE DERIVATIVE

A compound (8) represented by the formula: (8) wherein R1 represents a 6- to 14-membered aromatic hydrocarbon ring group which may have a substituent; and n represents 0 to 2, can be produced with good efficiency by reacting a compound (3) represented by the formula: (3) wherein R1 and n are as defined above; and Q represents a single bond or -CH(Y)- where Y represents a hydrogen atom or a C1-6 alkyl group] with 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde in the presence of a base.

Morpholine type cinnamide compound

The present invention relates to a compound represented by the formula (I): or a pharmacologically acceptable salt thereof, wherein R1, R2, R3, and R4 are the same or different and each represent a hydrogen atom or a C1-6 alkyl group; X1 represents a C1-6 alkylene group that may be substituted; Xa represents a methoxy group or a fluorine atom; Xb represents an oxygen atom or a methylene group, provided that Xb is only an oxygen atom when Xa is a methoxy group; and Ar1 represents an aryl group, pyridinyl group, aryloxy group, or pyridinyloxy group that may have a substituent such as a halogen atom; and to use of the compound or salt as a pharmaceutical agent.